Page last updated: 2024-10-31

mitotane and Pancreatic Neoplasms

mitotane has been researched along with Pancreatic Neoplasms in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baur, J1
Schedelbeck, U1
Pulzer, A1
Bluemel, C1
Wild, V1
Fassnacht, M1
Steger, U1

Other Studies

1 other study available for mitotane and Pancreatic Neoplasms

ArticleYear
A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma.
    BMC surgery, 2015, Jul-31, Volume: 15

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Chemotherapy, A

2015